Mingyue Lun
- Molecular Biology top 10%
- Physiology top 5%
- Cardiology and Cardiovascular Medicine top 5%
- Epidemiology top 10%
- Cancer Research
- Co-authors
- Matthew L. SteinhauserPing L. ZhangParth PatwariRobert BrownPouneh K. FazeliChristelle GuillermierLawrence I. RothblumMei Wang
- Topics
- Cardiomyopathy and Myosin Studies (5 papers)Adipose Tissue and Metabolism (4 papers)PI3K/AKT/mTOR signaling in cancer (3 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Mingyue Lun
29 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Molecular Biology 803
- Physiology 371
- Cardiology and Cardiovascular Medicine 337
- Epidemiology 256
- Cancer Research 152
Countries citing papers authored by Mingyue Lun
This map shows the geographic impact of Mingyue Lun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyue Lun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyue Lun more than expected).
Fields of papers citing papers by Mingyue Lun
This network shows the impact of papers produced by Mingyue Lun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyue Lun. The network helps show where Mingyue Lun may publish in the future.
Co-authorship network of co-authors of Mingyue Lun
This figure shows the co-authorship network connecting the top 25 collaborators of Mingyue Lun. A scholar is included among the top collaborators of Mingyue Lun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingyue Lun. Mingyue Lun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in micebreakdown → | 106 |
| 2 | 17 | |
| 3 | 42 | |
| 4 | 24 | |
| 5 | 138 | |
| 6 | 97 | |
| 7 | MYBPC3 Mutations Cause Hypertrophic Cardiomyopathy by Dysregulating Myosin: Implications for Therapy | 1 |
| 8 | 25 | |
| 9 | 54 | |
| 10 | 175 | |
| 11 | C4d positivity is often associated with acute cellular rejection in renal transplant biopsies following Campath-1H (Alemtuzumab) induction. | 8 |
| 12 | 32 | |
| 13 | 51 | |
| 14 | 27 | |
| 15 | Nuclear factor-kappaB pathway as a therapeutic target in head and neck squamous cell carcinoma: pharmaceutical and molecular validation in human cell lines using Velcade and siRNA/NF-kappaB. | 36 |
| 16 | Pamidronate resistance and associated low ras levels in breast cancer cells: a role for combinatorial therapy. | 10 |
| 17 | 30 | |
| 18 | 109 | |
| 19 | 2 | |
| 20 | 13 |
About Mingyue Lun
Mingyue Lun is a scholar working on Transplantation, Toxicology and Nephrology, having authored 29 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (5 papers), Adipose Tissue and Metabolism (4 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (337 citations), Physiology (371 citations) and Aging (23 citations). Mingyue Lun has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Matthew L. Steinhauser, Ping L. Zhang, Parth Patwari, Robert Brown, Pouneh K. Fazeli, Christelle Guillermier, Lawrence I. Rothblum, Mei Wang, Samuel E. Senyo and Anne Klibanski. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.